Document is current
Any future updates will be listed below
-
Authors
Wang, Yuncheng
Stevens, Maxwell T.
Wang, Trixie
Alreja, Adit B.
Nelson, Daniel C.
Britton, Warwick J.
Chan, Hak-Kim
-
Funding
Funding for this research was provided by:
National Institutes of Health (USA) award (R01AI168313)
National Health and Medical Research Council grant (APP1153493)
The University of Sydney
- License Information
-
More Information
Article History
Received: 25 July 2025
Accepted: 23 September 2025
First Online: 12 January 2026
Declarations
:
: D.C.N. is the inventor of a patent related to Cpl-1, a scientific advisor to Lysando A.G., and a co-founder of ExoLytics, Inc., both companies related to endolysin-derived technologies.
